Cited by 129Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchGenetic Associations and Epidemiology

Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease

Open access
EADI consortium, GERAD consortium, Lambert, J-C, Grenier-Boley, B, Harold, D, Zelenika, D, Chouraki, V, Kamatani, Y, Sleegers, K +67 more·2013·Molecular Psychiatry

Abstract

Recently, several genome-wide association studies (GWASs) have led to the discovery of nine new loci of genetic susceptibility in Alzheimer's disease (AD). However, the landscape of the AD genetic susceptibility is far away to be complete and in addition to single-SNP (single-nucleotide polymorphism) analyses as performed in conventional GWAS, complementary strategies need to be applied to overcome limitations inherent to this type of approaches. We performed a genome-wide haplotype association (GWHA) study in the EADI1 study (n=2025 AD cases and 5328 controls) by applying a sliding-windows approach. After exclusion of loci already known to be involved in AD (APOE, BIN1 and CR1), 91 regions with suggestive haplotype effects were identified. In a second step, we attempted to replicate the best suggestive haplotype associations in the GERAD1 consortium (2820 AD cases and 6356 controls) and observed that 9 of them showed nominal association. In a third step, we tested relevant haplotype associations in a combined analysis of five additional case-control studies (5093 AD cases and 4061 controls). We consistently replicated the association of a haplotype within FRMD4A on Chr.10p13 in all the data set analyzed (OR: 1.68; 95% CI: (1.43-1.96); P=1.1 × 10(-10)). We finally searched for association between SNPs within the FRMD4A locus and Aβ plasma concentrations in three independent non-demented populations (n=2579). We reported that polymorphisms were associated with plasma Aβ42/Aβ40 ratio (best signal, P=5.4 × 10(-7)). In conclusion, combining both GWHA study and a conservative three-stage replication approach, we characterised FRMD4A as a new genetic risk factor of AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/mp.2012.14

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 32

  1. Hardy J Selkoe D The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 2002 297 353 356 12130773
  2. Small SA Duff K Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis Neuron 2008 60 534 542 19038212 PMC2692134
  3. Lambert JC Amouyel P Genetic heterogeneity of Alzheimer's disease: complexity and advances Psychoneuroendocrinology 2007 32 S62 S70 17659844
  4. Genin E Hannequin D Wallon D Sleegers K Hiltunen M Combarros O APOE and Alzheimer disease: a major gene with semi-dominant inheritance Mol Psychiatry 2011 16 903 907 21556001 PMC3162068
  5. Lambert JC Heath S Even G Campion D Sleegers K Hiltunen M Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease Nat Genet 2009 41 1094 1099 19734903
  6. Seshadri S Fitzpatrick AL Ikram MA DeStefano AL Gudnason V Boada M Genome-wide analysis of genetic loci associated with Alzheimer disease JAMA 2010 303 1832 1840 20460622 PMC2989531
  7. Hollingworth P Harold D Sims R Gerrish A Lambert JC Carrasquillo MM Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease Nat Genet 2011 43 429 435 21460840 PMC3084173
  8. Lambert JC Amouyel P Genetics of Alzheimer's disease: new evidences for an old hypothesis Curr Opin Genet Dev 2011 21 295 301 21371880
  9. Trégouët DA König IR Erdmann J Munteanu A Braund PS Hall AS Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease Nat Genet 2009 41 283 285 19198611
  10. McKhann G Drachman D Folstein M Katzman R Price D Stadlan EM Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of Health and Human services task force on Alzheimer's disease Neurology 1984 34 939 944 6610841
  11. Mirra SS Heyman A McKeel D Sumi SM Crain BJ Brownlee LM The consortium to establish a registry for Alzheiemr's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease Neurology 1991 41 479 486 2011243
  12. Van Oijen M Hofman A Soares HD Koudstaal PJ Breteler MM Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study Lancet Neurol 2006 5 655 660 16857570
  13. Lambert JC Schraen-Maschke S Richard F Fievet N Rouaud O Berr C Association of plasma amyloid beta with risk of dementia: the prospective three-city study Neurology 2009 73 847 853 19752451
  14. Lopez OL Kuller LH Mehta PD Becker JT Gach HM Sweet RA Plasma amyloid levels and the risk of AD in normal subjects in the cardiovascular health study Neurology 2008 70 1664 1671 18401021 PMC2670993
  15. Mathias RA Gao P Goldstein JL Wilson AF A graphical assessment of P-values from sliding window haplotype tests of association to identify asthma susceptibility loci on chromosome 11q BMC Genet 2006 7 38 16774684 PMC1526454
  16. Yu Z Schaid DJ Sequential haplotype scan methods for association analysis Genet Epidemiol 2007 31 553 564 17487883
  17. Huang BE Amos CI Lin DY Detecting haplotype effects in genome wide association studies Genet Epidemiol 2007 31 803 812 17549762
  18. Tregouet DA Ricard S Nicaud V Arnould I Soubigou S Rosier M In-depth haplotype analysis of ABCA1 gene polymorphisms in relation to plasma ApoA1 levels and myocardial infarction Arterioscler Thromb Vasc Biol 2004 24 775 781 14962947
  19. Tregouet DA Escolano S Tiret L Mallet A Golmard JL A new algorithm for haplotype-based association analysis: the stochastic-EM algorithm Ann Hum Genet 2004 68 165 177 15008795
  20. Tregouet DA Garelle V A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies Bioinformatics 2007 23 1038 1039 17308338
  21. Gagliardi F Jones B Grey F Bégin ME Heikkurinen M Building an infrastructure for scientific grid computing: status and goals of the EGEE project Philos Transact A Math Phys Eng Sci 2005 363 1729 1742 16099744
  22. Ikenouchi J Umeda M FRMD4A regulates epithelial polarity by connecting Arf6 activation with the PAR complex Proc Natl Acad Sci USA 2010 107 748 753 20080746 PMC2818900
  23. Sannerud R Declerck I Peric A Raemaekers T Menendez G Zhou L ADP ribosylation factor 6 (ARF6) controls amyloid precursor protein (APP) processing by mediating the endosomal sorting of BACE1 Proc Natl Acad Sci USA 2011 108 E559 E568 21825135 PMC3161548
  24. Hamshere ML Holmans PA Avramopoulos D Bassett SS Blacker D Bertram L Genome-wide linkage analysis of 723 affected relative pairs with late-onset Alzheimer's disease Hum Mol Genet 2007 16 2703 2712 17725986
  25. Tepass U FERM proteins in animal morphogenesis Curr Opin Genet Dev 2009 19 357 367 19596566
  26. Hernández-Deviez DJ Casanova JE Wilson JM Regulation of dendritic development by the ARF exchange factor ARNO Nat Neurosci 2002 5 623 624 12032543
  27. Albertinazzi C Za L Paris S de Curtis I ADP-ribosylation factor 6 and a functional PIX/p95-APP1 complex are required for Rac1B-mediated neurite outgrowth Mol Biol Cell 2003 14 1295 1307 12686588 PMC153101
  28. Mehta PD Pirttila T Patrick BA Barshatzky M Mehta SP Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease Neurosci Lett 2001 304 102 106 11335065
  29. Vanderstichele H Van Kerschaver E Hesse C Davidsson P Buyse MA Andreasen N Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma Amyloid 2000 7 245 258 11132093
  30. Giedraitis V Sundelöf J Irizarry MC Gårevik N Hyman BT Wahlund LO The normal equilibrium between CSF and plasma amyloid beta levels is disrupted in Alzheimer's disease Neurosci Lett 2007 427 127 131 17936506
  31. Soscia SJ Kirby JE Washicosky KJ Tucker SM Ingelsson M Hyman B The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide PloS One 2010 5 e9505 20209079 PMC2831066
  32. Lambert JC Dallongeville J Ellis KA Schraen-Maschke S Lui J Laws S Association of plasma Aβ peptides with blood pressure in the elderly PloS One 2011 6 e18536 21525986 PMC3078119

Cited by

Sorted by citations

Authors
EADI consortium, G. C., Lambert, J.-C., Grenier-Boley, B., Harold, D., Zelenika, D., Chouraki, V, Kamatani, Y., Sleegers, K., Ikram, M. A., Hiltunen, M., Reitz, C., Mateo, I., Feulner, T., Bullido, M., Galimberti, D., Concari, L., Alvarez, V, Sims, R., Gerrish, A., Chapman, J., Deniz-Naranjo, C., Solfrizzi, V, Sorbi, S., Arosio, B., Spalletta, G., Siciliano, G., Epelbaum, J., Hannequin, D., Dartigues, J.-F., Tzourio, C., Berr, C., Schrijvers, E. M. C., Rogers, R., Tosto, G., Pasquier, F., Bettens, K., Van Cauwenberghe, C., Fratiglioni, L., Graff, C., Delepine, M., Ferri, R., Reynolds, C. A., Lannfelt, L., Ingelsson, M., Prince, J. A., Chillotti, C., Pilotto, A., Seripa, D., Boland, A., Mancuso, M., Bossù, P., Annoni, G., Nacmias, B., Bosco, P., Panza, F., Sanchez-Garcia, F., Del Zompo, M., Coto, E., Owen, M., O'Donovan, M., Valdivieso, F., Caffara, P., Scarpini, E., Combarros, O., Buée, L., Campion, D., Soininen, H., Breteler, M., Riemenschneider, M., Van Broeckhoven, C., Alpérovitch, A., Lathrop, M., Trégouët, D.-A., Williams, J., & Amouyel, P.
Affiliations
  • Inserm (FR)
  • Cardiff University (GB)
  • Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
  • University of Antwerp (BE)
  • Erasmus MC (NL)
  • University of Eastern Finland (FI)
  • Columbia University (US)
  • Universidad de Cantabria (ES)
  • Universitätsklinikum des Saarlandes (DE)
  • Biomedical Research Networking Center on Neurodegenerative Diseases (ES)
  • University of Milan (IT)
  • University of Parma (IT)
  • Hospital Universitario de Gran Canaria Doctor Negrín (ES)
  • University of Bari Aldo Moro (IT)
  • University of Florence (IT)
  • Fondazione Santa Lucia (IT)
  • University of Pisa (IT)
  • Centre Hospitalier Universitaire de Lille (FR)
  • Karolinska University Hospital (SE)
  • Oasi Maria SS (IT)
  • University of California, Riverside (US)
  • Uppsala University (SE)
  • Karolinska Institutet (SE)
  • University of Cagliari (IT)
  • Casa Sollievo della Sofferenza (IT)
  • Hospital Universitario Central de Asturias (ES)
  • German Center for Neurodegenerative Diseases (DE)
Corresponding author
Lambert, J-C
Venue
Molecular Psychiatry
Published
2012-03-20
Volume
18
Issue
4
Pages
461-470
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W2138023910
Cited by
129
References
4
Citations by year
2026: 2 · 2025: 9 · 2024: 18 · 2023: 4 · 2022: 13 · 2021: 7 · 2020: 9 · 2019: 10 · 2018: 8 · 2017: 10 · 2016: 12 · 2015: 6 · 2014: 7 · 2013: 12 · 2012: 2
FWCI
5.79
Type
journal article
Language
en
Update notices
erratum (2012-09-18)
Open access
Locations
  • Molecular Psychiatry (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
  • HAL (submittedVersion, cc-by-nc-sa)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
  • CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
  • BOA (University of Milano-Bicocca) (submittedVersion, cc-by-nc-sa)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
  • Florence Research (University of Florence) (submittedVersion)
  • ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
  • UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
  • DZNE Pub (submittedVersion)
  • CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
Funders
  • Institut National de la Santé et de la Recherche Médicale
  • Medical Research Council (MR/K013041/1)
  • National Institute on Aging (R01AG004563, AG-10175, AG04563, K23AG034550, AG 08724, AG028555, R01AG028555, AG 08861, R01AG010175, R01AG008724)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords
Alzheimer's disease, haplotype association, genetic susceptibility, amyloid-beta 42/40 ratio, plasma amyloid-beta, single nucleotide polymorphisms
MeSH terms
Alzheimer Disease, Haplotypes, Humans, Case-Control Studies, Amyloid beta-Peptides, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Adaptor Proteins, Signal Transducing, Genome-Wide Association Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review